Startups

Associate Director, Clinical Science

Braveheart · San Francisco, CA or Remote or Hybrid · Remote

← All jobs
About Braveheart

Advancing treatments to improve outcomes and quality of life for patients with hypertrophic cardiomyopathy and related heart conditions. Backed by a16z.

About the role

The Associate Director, Clinical Science will serve as a key scientific contributor within Braveheart Bio's Clinical Development organization, partnering closely with the Clinical Development Medical Directors to shape and execute the clinical and translational science strategy for BHB-1893 across the hypertrophic cardiomyopathy spectrum (oHCM and nHCM). Found on 1752vc Careers, the job board for startup and VC roles.

What they're looking for

  • PhD or equivalent research doctorate (field flexible), other advanced degrees (e.g., PharmD, MS with substantial relevant experience) will be considered
  • 6+ years of experience in clinical development and/or translational research
  • Demonstrated experience conducting hands-on review and quality control of clinical data listings
  • Experience collaborating with co-development partners, CROs, or other external organizations on clinical data review, cleaning, and reconciliation, ideally in global Phase 3 trials through database lock
  • Strong independent data analysis skills, including the ability to identify patterns, anomalies, and scientific signals in complex clinical datasets
  • Working knowledge of cardiovascular disease biology, ideally including sarcomere biology and hypertrophic cardiomyopathy
More about this role

Braveheart Bio is a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases. Our lead product candidate, BHB-1893, is a next-generation oral small-molecule cardiac myosin inhibitor (CMI) being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM). Braveheart’s goal is to improve the treatment options for these patients by enhancing speed of onset, depth of gradient response, systolic safety, reversibility and reducing prescribing complexity.

With a proven leadership team, a strong financial foundation, and a high-value late-stage asset, Braveheart Bio represents an outstanding opportunity for ambitious, mission-driven professionals to make a tangible impact in a high-profile and rapidly evolving therapeutic area.

The Associate Director, Clinical Science will serve as a key scientific contributor within Braveheart Bio's Clinical Development organization, partnering closely with the Clinical Development Medical Directors to shape and execute the clinical and translational science strategy for BHB-1893 across the hypertrophic cardiomyopathy...

Read the full posting on Braveheart's site ↗

Clinical Science

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.